Friday, March 29, 2024 | Ramadan 18, 1445 H
clear sky
weather
OMAN
25°C / 25°C
EDITOR IN CHIEF- ABDULLAH BIN SALIM AL SHUEILI

Scott Gottlieb nominated as FDA head

951672
951672
minus
plus

WASHINGTON:  US President Donald Trump has chosen Dr  Scott Gottlieb (pictured), a conservative health policy expert with deep ties to the pharmaceutical industry, to lead the US Food and Drug Administration, the White House said on Friday. If confirmed by the Senate, Gottlieb would be in charge of implementing Trump’s plan to dramatically cut regulations governing food, drugs, cosmetics, dietary supplements and tobacco. Gottlieb is well known on Capitol Hill, where he has testified multiple times on hot-button health issues, including complex drug pricing matters, and is viewed favourably by drug companies and pharmaceutical investors. He sits on the boards of several small drug and biotech companies and is an adviser to GlaxoSmithKline Plc.


“Thank God it’s Gottlieb,” Brian Skorney, an investment analyst at Robert W Baird, wrote in a research note. “We view this as a favourable development for the sector.” Gottlieb was chosen over Jim O’Neill, a libertarian investor close to Silicon Valley billionaire Peter Thiel, a PayPal co-founder who now advises Trump on technology and science matters. O’Neill’s stated view that drugs should be approved before being proven effective generated widespread alarm.  Gottlieb, 44, is a resident fellow at the conservative American Enterprise Institute think tank. — Reuters


SHARE ARTICLE
arrow up
home icon